NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 4, 40
- https://doi.org/10.3389/fendo.2013.00040
Abstract
Predictions of diabetes prevalence over the next decades warrant the aggressive discovery of new approaches to stop or reverse loss of functional beta cell mass. Beta cells are recognized to have a relatively high sensitivity to reactive oxygen species (ROS) and become dysfunctional under oxidative stress conditions. New discoveries have identified NADPH oxidases in beta cells as contributors to elevated cellular ROS. Reviewed are recent reports that evidence a role for NADPH oxidase-1 (NOX-1) in beta cell dysfunction. NOX-1 is stimulated by inflammatory cytokines that are elevated in diabetes. First, regulation of cytokine-stimulated NOX-1 expression has been linked to inflammatory lipid mediators derived from 12-lipoxyganase activity. For the first time in beta cells these data integrate distinct pathways associated with beta cell dysfunction. Second, regulation of NOX-1 in beta cells involves feed-forward control linked to elevated ROS and Src-kinase activation. This potentially results in unbridled ROS generation and identifies candidate targets for pharmacologic intervention. Third, consideration is provided of new, first-in-class, selective inhibitors of NOX-1. These compounds could have an important role in assessing a disruption of NOX-1/ROS signaling as a new approach to preserve and protect beta cell mass in diabetes.Keywords
This publication has 109 references indexed in Scilit:
- Discovery of Potent and Selective Inhibitors of Human Platelet-Type 12- LipoxygenaseJournal of Medicinal Chemistry, 2011
- ROS signaling: the new wave?Trends in Plant Science, 2011
- Phagocyte-like NADPH oxidase generates ROS in INS 832/13 cells and rat islets: role of protein prenylationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Functional and pathological roles of the 12- and 15-lipoxygenasesProgress in Lipid Research, 2011
- Phagocyte-like NADPH oxidase promotes cytokine-induced mitochondrial dysfunction in pancreatic β-cells: evidence for regulation by Rac1American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalencePopulation Health Metrics, 2010
- NADPH Oxidase NOX1 Controls Autocrine Growth of Liver Tumor Cells through Up-regulation of the Epidermal Growth Factor Receptor PathwayJournal of Biological Chemistry, 2010
- 12-Lipoxygenase Products Reduce Insulin Secretion and β-Cell Viability in Human IsletsJournal of Clinical Endocrinology & Metabolism, 2010
- Small G Proteins in Islet β-Cell FunctionEndocrine Reviews, 2009
- Diabetes associated cell stress and dysfunction: role of mitochondrial and non‐mitochondrial ROS production and activityThe Journal of Physiology, 2007